2 We prescribe your treatment Our US-based team determines your eligibility for treatment and issues your prescription
Lancet 394:131138 Tuttle KR, Lakshmanan MC, Rayner B, Busch RS, Zimmermann AG, Woodward DB et al (2018) Dulaglutide versus insulin glargine in patients with type 2 diabetes and moderate-to-severe chronic kidney disease (AWARD-7): a multicentre, open-label, randomised trial
Available at: www.ohri.ca/programs/clinical_epidemiology/oxford.asp
By choosing a liposomal delivery system, you ensure that your body can actually use the "master antioxidant" to support your immune system, liver health, and cellular longevity
Glucagon-like Peptide-1 receptor Tie2 + cells are essential for the cardioprotective actions of liraglutide in mice with experimental myocardial infarction